Clinical Trial Update: Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy [Phase 3]

View source ↗

Summary

Phase III trial evaluating DP-R208 and each monotherapy for hypertension and hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hypertension

Drugs mentioned

• DP-R208

Snippet

Sponsor: Alvogen Korea | Conditions: Hypertension, Cholesterolemia | Phase 3 | Status: COMPLETED